| NCT ID | NCT06222333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kastamonu University |
| Condition | Rib Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2024-11-13 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Respiratory physiotherapy is routinely performed after thoracic surgery operations to increase lung expansion and prevent pulmonary complications such as atelectasis and pneumonia. It is a controversial issue whether respiratory physiotherapy reduces pulmonary complications in rib fractures. In our study, patients with rib fractures will be divided into two groups. In the control group, standard treatment consisting of routine analgesic treatments will be applied. In the other group, respiratory physiotherapy will be applied with triflu for 8 hours a day. At the end of the study, pulmonary complications in both groups will be compared.
Eligibility Criteria
Inclusion Criteria: * Isolated thoracic injury within 24 hours * Age between 18-100 Exclusion Criteria: * Pneumothorax and hemothorax requiring intervention at admission * Injury severity index \>16 * COPD, Atshma * Extrathoracic trauma
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06222333 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Rib Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06222333 currently recruiting?
Yes, NCT06222333 is actively recruiting participants. Contact the research team at drismaildal@gmail.com for enrollment information.
Where is the NCT06222333 trial being conducted?
This trial is being conducted at Kastamonu, Turkey (Türkiye).
Who is sponsoring the NCT06222333 clinical trial?
NCT06222333 is sponsored by Kastamonu University. The trial plans to enroll 62 participants.